Mylan Gets OK for Prilosec Equivalent
- Share via
From Reuters
Mylan Laboratories Inc. said regulators approved its application for a generic version of heartburn drug Prilosec. The Food and Drug Administration approved Mylan’s application for delayed-release 10-milligram and 20-milligram versions of the drug, and gave tentative approval to the 40-milligram version.
It was unclear when Mylan would launch its version of the drug. AstraZeneca, which makes Prilosec, has sued Mylan and other potential generic competitors.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.